During her career, Barbara Haley, M.D., has dedicated herself to treating breast cancer patients, understanding more about the disease, and advancing treatment options. She has been involved with remarkable transformations to treat breast cancer more effectively, while minimizing side effects for patients.
Dr. Haley’s expertise as a medical oncologist is applying and advancing therapeutic agents to treat breast cancer, including chemotherapy, hormonal therapy, and biologic agents. She is committed to understanding the entirety of a patient’s needs and delivering customized, comprehensive treatment plans.
Dr. Haley leads multiple clinical trials at UT Southwestern related to therapeutic treatments of breast cancer. She is a member of UT Southwestern’s Center for Breast Care’s Executive Committee. As part of this team, she spearheaded the Center’s comprehensive approach to screening, staging, and treating breast cancer. The result is a multidisciplinary approach to care that supports the patient by utilizing case conferences among team members, coordinated planning, screening for genetic mutations, an array of support services, and access to electronic medical records.
Dr. Haley has participated in groundbreaking national and international clinical trials, such as those involving HER-2, nonadjuvant therapies, genetic influences on lymphedema and potential evacuation, and the impact of breast cancer treatments on postmenopausal women. Her work with nanoparticles is supporting the development of new delivery systems for drugs that will be more effective in targeting breast cancer cells.
She has published numerous scientific articles on breast cancer. This includes the assessment of HER-2 in breast cancer treatment, and how zoledronic acid can affect bone loss in postmenopausal women receiving adjuvant therapy for breast cancer.
Dr. Haley is a Fellow of the American College of Physicians. She is a member of the American Society of Clinical Oncology and the American Society of Hematology, as well as the Texas Medical Association and Dallas County Medical Society.
After graduating from UT Southwestern Medical Center, Dr. Haley completed her internship, residency, and fellowship at Parkland Health & Hospital System. She was named the Charles Cameron Sprague, M.D., Chair in Clinical Oncology in 2006.
Dr. Haley has received local and national recognition, including Best Doctors in America by U.S. News & World Report, Best Doctors in Dallas by D Magazine, and a Super Doctor by Texas Monthly.